Buprenorphine Transdermal Patch Suppliers & Bulk Manufacturers
Available Forms: Transdermal Patch
Available Strengths: 5 mcg/hr, 10 mcg/hr, 15 mcg/hr, 20 mcg/hr
Reference Brands: Butrans(US)
Category: Analgesic
Buprenorphine transdermal patches activate mu-opioid receptors, blocking pain signals and altering pain perception for sustained relief. Benefits include long-lasting, effective pain control, improved patient adherence due to convenience, and a lower risk of overdose compared to other opioids when used responsibly and monitored carefully. Buprenorphine Transdermal Patch is available in Transdermal Patch and strengths such as 5 mcg/hr, 10 mcg/hr, 15 mcg/hr, 20 mcg/hr. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Buprenorphine Transdermal Patch is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Buprenorphine Transdermal Patch can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Buprenorphine transdermal patches are approved in both the EU and US for managing severe pain. In the EU, brands like Butrans are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and rigorous manufacturing standards. In the US, FDA approval is based on extensive clinical data; generics are also available. Both regions enforce strict regulations, including prescribing controls and pharmacovigilance due to the potential for abuse. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support seamless market access for buprenorphine patches, ensuring adherence to European and American standards for safe, effective pain management in opioid-tolerant patients.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Buprenorphine Transdermal Patch is used for the management of moderate to severe chronic pain that requires continuous, long-term opioid treatment. It delivers a controlled dose of buprenorphine through the skin over several days.
It is made from buprenorphine, a semi-synthetic opioid, embedded in a transdermal system that releases the drug steadily through the skin into the bloodstream.
The commonly known trade names are Butrans and Transtec.
Butrans is marketed by Purdue Pharma / Collegium Pharmaceutical in some regions, while Transtec is produced by Grünenthal. Several companies also manufacture generic patches.
The generic name is buprenorphine transdermal system (buprenorphine).
The well-known brand names include Butrans and Transtec.
It is manufactured in various countries including India, the USA, and several European regions by both branded and generic pharmaceutical manufacturers.
Related Products
Methocarbamol
Strength:
500 mg, 750 mg
Form: Tablet / Injection
Reference Brands: Robaxin (USA/EU), Carbacot (USA/EU)
View Details
Meperidine Hydrochloride
Strength:
50 mg, 100 mg, 50 mg/5 mL
Form: Tablets/ Injectable / Oral Solution
Reference Brands: Demerol (USA)
View Details
Meclofenamate
Strength:
50 mg, 100 mg
Form: Tablets
Reference Brands: Meclomen (USA), Mecloflam (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
